New footprint complements existing Montreal office to strengthen the company’s presence across Canada TORONTO, May 21, 2026 (GLOBE NEWSWIRE) — OpenTable, a global leader in restaurant technology, announced today that it has signed a multi-year lease agreement for its new Toronto office at Allied’s 134 Peter Street in the city’s Downtown West neighbourhood. With over 24,000 square feet of premium office space secured, this marks a commitment to the Canadian market and a significant milestone in OpenTable’s ongoing international expansion. Expanding upon OpenTable’s established presence in Montreal, this new Toronto location broadens the company’s office footprint in Canada, serving as a hub for its Canadian operations and global engineering team. A portion of the local team will focus on product development and backend infrastructure...

REDMOND, Wash., May 21, 2026 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Data I/O Corporation, please note that in the 2026 business framework section in the third bullet list, the part that said “implying a minimum of approximately 20% sequential growth from the first quarter” should have said “implying a minimum of over 50% sequential growth from the first quarter”.  The corrected release follows:  Data I/O Corporation (NASDAQ: DAIO) (the “Company”), the leading global provider of data provisioning solutions for flash memory, microcontrollers and security ICs, today announced that it will be presenting at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub on Wednesday, June 17, 2026 at 11:00 AM PST at the Bellagio Resort & Hotel. William...

PARIS, France and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announces the pricing of its previously announced global follow-on offering, consisting of (i) a public offering of 225,373 American Depositary Shares (“ADSs”), each ADS representing one ordinary share, €0.03 nominal value per share (each an “Ordinary Share”), of the Company, in the United States (the “U.S. Offering”) at an offering price of $38.98 per ADS, and (ii) an offering of (a) 1,959,289 Ordinary Shares and (b) 345,099 pre-funded warrants to subscribe for one Ordinary Share each (the “PFW”), exclusively to “qualified...

PARIS, France and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “Nanobiotix” or the “Company”), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announces the pricing of its previously announced global follow-on offering, consisting of (i) a public offering of 225,373 American Depositary Shares (“ADSs”), each ADS representing one ordinary share, €0.03 nominal value per share (each an “Ordinary Share”), of the Company, in the United States (the “U.S. Offering”) at an offering price of $38.98 per ADS, and (ii) an offering of (a) 1,959,289 Ordinary Shares and (b) 345,099 pre-funded warrants to subscribe for one Ordinary Share each (the “PFW”), exclusively to “qualified...

MIRAMAR, Fla., May 21, 2026 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”), (NASDAQ: HCWB), a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to treat autoimmune, cancer and senescence-associated dysplasia, today announced the pricing of its private placement of an aggregate of 2,846,975 units at a purchase price of $1.405 per unit priced at-the-market under Nasdaq rules to a group of healthcare investors (the “Investors”). Each unit consists of (i) one share of common stock at a purchase price of $1.28 per share (or, in lieu thereof, one pre-funded warrant at a purchase price of $1.2799 per pre-funded warrant with an exercise price of $0.0001 per share) and (ii) one warrant at a purchase price of $0.125 per warrant, each to purchase one share of common stock....

21 May 2026 Information pursuant to article L. 233-8 II of the Code de commerce and articles 223-16 and 223-11 of the AMF General regulation (Règlement général de l’Autorité des marchés financiers)Date Number of shares with a nominal value of €7 Gross number ofvoting rights21 May 2026         462,616,024 462,616,024    About Alstom Alstom is the pure rail leader, committed to making rail the backbone of sustainable transportation. We design and deliver a complete range of future-ready solutions – from high-speed and regional trains to metros, monorails, trams, turnkey systems, end-to-end services, infrastructure, signalling and digital rail solutions. With 87,800 people in 61 countries, Alstom brings together global expertise and multi-local presence to make every journey smarter, cleaner and more enjoyable. Together with...

Business ranks first in Quality of Service, No. 2 in Breadth of Service, No. 3 in Size of Deal categories TROY, Mich., May 21, 2026 (GLOBE NEWSWIRE) — KellyOCG®, the outsourcing and consulting business of Kelly® (Nasdaq: KELYA, KELYB), a global workforce strategy and solutions provider, has claimed the top spot on HRO Today’s 2026 Baker’s Dozen Customer Satisfaction Ratings™ for MSP in Contingent Labor Resourcing and Management. KellyOCG also ranks No. 1 in Quality of Service, No. 2 in Breadth of Service, and No. 3 in Size of Deal. Being named the top managed service provider (MSP) by HRO Today reflects KellyOCG’s relentless focus on client outcomes and innovation. The Baker’s Dozen rankings are determined exclusively by feedback from buyers through an online survey and are a direct reflection of client...